NetworkNewsBreaks Archive - Page 2082 of 2082

WednesdaySep 21, 2016 7:43 am

BioLineRx Ltd. (BLRX) Initiates Phase 2a Trial for Pancreatic Cancer Therapy

BioLineRx Ltd. (NASDAQ: BLRX) announced that it has initiated a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA (pembrolizumab), MSD's anti-PD-1 therapy, in patients with metastatic pancreatic cancer. The study is designed to evaluate the safety and efficacy of the combination of BL-8040 and KEYTRUDA in up to 30 subjects with metastatic pancreatic adenocarcinoma. The study is designed to evaluate the clinical response, safety and tolerability of the combination of these therapies as well as multiple pharmacodynamic parameters, including the ability to improve infiltration of T cells into the tumor and their reactivity. To view the full press release,…

WednesdaySep 21, 2016 7:40 am

Airgain, Inc. (AIRG) Announces Q2 2016 Financial Results

Airgain, Inc. (NASDAQ : AIRG) today reported results for the second quarter ended June 30, 2016. Sales increased 63% to $9.9 million year over year, gross profit increased 79% to $4.5 million year over year, total operating expenses increased 31% year over year, and net income attributable to common stockholders totaled $700,428 versus a loss of $781,689 a year ago. Other key metrics include a 62% increase in total customer devises to 12 million, a 24% increase in the average number of antennas per device, and a 1% decrease in the average selling price per device. To view the full…